KAYS (Kaya Holdings) Cyclically Adjusted PS Ratio: (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kaya Holdings Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Kaya Holdings  (OTCPK:KAYS) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Kaya Holdings Cyclically Adjusted PS Ratio Related Terms


Kaya Holdings Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Kaya Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaya Holdings Cyclically Adjusted PS Ratio Chart

Kaya Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.81 0.52 0.00

Kaya Holdings Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

KAYS vs APUS, IGPK, BIOE: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kaya Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kaya Holdings Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kaya Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Kaya Holdings's Cyclically Adjusted PS Ratio falls into.



Kaya Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Kaya Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2025 is calculated as:

For example, Kaya Holdings's adjusted Revenue per Share data for the three months ended in Sep. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2025 (Change)*Current CPI (Sep. 2025)
=0/324.8000*324.8000
=0.000

Current CPI (Sep. 2025) = 324.8000.

Kaya Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201512 0.039 236.525 0.054
201603 0.039 238.132 0.053
201606 0.036 241.018 0.049
201609 0.039 241.428 0.052
201612 0.025 241.432 0.034
201703 0.018 243.801 0.024
201706 0.023 244.955 0.030
201709 0.037 246.819 0.049
201712 0.035 246.524 0.046
201803 0.012 249.554 0.016
201806 0.031 251.989 0.040
201809 0.029 252.439 0.037
201812 0.026 251.233 0.034
201903 0.007 254.202 0.009
201906 0.009 256.143 0.011
201909 0.007 256.759 0.009
201912 0.011 256.974 0.014
202003 0.019 258.115 0.024
202006 0.021 257.797 0.026
202009 0.020 260.280 0.025
202012 0.018 260.474 0.022
202103 0.017 264.877 0.021
202106 0.003 271.696 0.004
202109 0.003 274.310 0.004
202112 0.003 278.802 0.003
202203 0.013 287.504 0.015
202206 0.013 296.311 0.014
202209 0.012 296.808 0.013
202212 0.008 296.797 0.009
202303 0.000 301.836 0.000
202306 0.002 305.109 0.002
202309 0.000 307.789 0.000
202312 -0.007 306.746 -0.007
202403 0.000 312.332 0.000
202406 0.000 314.175 0.000
202409 0.000 315.301 0.000
202412 0.000 315.605 0.000
202503 0.000 319.799 0.000
202506 0.000 322.561 0.000
202509 0.000 324.800 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kaya Holdings Business Description

Address 21218 St. Andrews Boulevard, Suite 300, Boca Raton, FL, USA, 33433
Kaya Holdings Inc is a holding company. It is focusing on wellness and mental health through operations in psychedelic treatment clinics, medical and recreational cannabis, and CBD products. The company own and operate a medical cannabis dispensary in the United States. Its has produced, distributed, and/or sold a full range of premium cannabis products including flower, oils, vape cartridges and cannabis infused confections, baked goods and beverages through a fully integrated group of subsidiaries and companies supporting distinctive brands.